Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
05/2010
05/06/2010WO2010049302A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
05/06/2010US20100113796 Indole derivatives as s1p1 receptor
05/06/2010US20100113780 Heteromonocyclic compound and use thereof
05/06/2010US20100113777 INDOLE DERIVATIVES HAVING cPLA2 INHIBITING ACTIVITY AND APPLICATIONS AND PRODUCTION METHODS OF THE SAME
05/06/2010US20100113776 Pyrazole derivative
05/06/2010US20100113775 2-substituted-6-heterocyclic pyrimidone derivatives as tau protein kinase 1 inhibitors
05/06/2010US20100113774 Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions
05/06/2010US20100113772 2-Aminobenzoxazole Process
05/06/2010US20100113540 Azole and Thiazole Derivatives and Their Use
05/06/2010US20100113529 Dosage regimen for comt inhibitors
05/06/2010US20100113528 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (s1p) agonists
05/06/2010US20100113522 COMPOUNDS FOR THE MODULATION OF PPARgamma ACTIVITY
05/06/2010US20100113520 Kinase knockdown via electrophilically enhanced inhibitors
05/06/2010US20100113471 2-Aminoaryloxazole compounds as tyrosine kinase inhibitors
05/06/2010US20100113448 Oxazolidinone derivative having inhibitory activity on 11beta-hydroxysteroid dehydrogenase type 1
05/06/2010US20100113447 Triazole compounds that modulate hsp90 activity
05/06/2010US20100113445 Chemical Compounds
05/06/2010US20100113444 Prolyl hydroxylase inhibitors
05/06/2010US20100113440 Pyrimidine substituted macrocyclic hcv inhibitors
05/06/2010US20100113439 Antifungal agents
05/06/2010US20100113436 Dispiro tetraoxane compounds and their use in the treatment of malaria and/or cancer
05/06/2010US20100113435 Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1
05/06/2010US20100113424 N-benzyl pyrrolidine derivatives
05/06/2010US20100113415 Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer
05/06/2010US20100113414 Thiazolyl-dihydro-indazoles
05/06/2010US20100113388 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
05/06/2010US20100112708 Methods and Mixtures Pertaining to Analyte Determination Using Electrophilic Labeling Reagents
05/06/2010US20100111900 Heterocyclic antiviral compounds
05/06/2010US20100107478 Oxazolidines derived from polyalkyl or polyalkenyl n-hydroxyalkyl succinimides, obtainment process and use
05/06/2010CA2742007A1 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
05/06/2010CA2741661A1 Novel amide derivative and use thereof as medicine
05/06/2010CA2741153A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
05/06/2010CA2740558A1 Poly-heteroaryl derivatives for the treatment of cancer
05/06/2010CA2738776A1 7-azaspiro [3.5] nonane-7-carboxamide compounds as modulators of fatty acid amide hydrolase
05/05/2010EP2181994A1 Antimicrobial compounds
05/05/2010EP2181993A1 Antimicrobial oxazolidinone derivatives
05/05/2010EP2181985A1 Antiviral Agent
05/05/2010EP2181108A2 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases
05/05/2010EP2181100A2 Insecticidal aryl isoxazoline derivatives
05/05/2010EP2181092A1 1,3-dihydroisoindole derivatives
05/05/2010EP1997813B1 Substituted isoxazoline compound and pest control agent
05/05/2010EP1948648B1 3-aryl-isoxazole-4-carbonyl-benzofurane derivatives
05/05/2010EP1891001B1 SULFONAMIDE DERIVATIVES USEFUL AS LIVER CARNITINE PALMITOYL TRANSFERASE (L-CPTl) INHIBITORS
05/05/2010EP1615914B1 Cgrp receptor antagonists
05/05/2010EP1485100B1 Azinylaminoazoles as inhibitors of protein kinases
05/05/2010EP1474147B1 Pyrimidine-based compounds useful as gsk-3 inhibitors
05/05/2010EP1417206B1 Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
05/05/2010EP1167366B1 Amine derivatives
05/05/2010CN1910177B Substituted quinolines and their use as mycobacterial inhibitors
05/05/2010CN1878767B Azole-based kinase inhibitors
05/05/2010CN1832925B New P2X7 receptor avtagonists and their use
05/05/2010CN101702907A Piperazine compounds with a herbicidal action
05/05/2010CN101702905A Functionally selective alpha 2C adrenoreceptor agonists
05/05/2010CN101701006A Phenethanolamine derivatives for treatment of respiratory diseases
05/04/2010US7709661 Indole is treated with an aldehyde in the presence of a Lewis acid and a silicon hydride reducing agent, alkylating the C-3 position of indoles that contain acid-sensitive substituents at the N-1 position
05/04/2010US7709636 Such as N-((4,6-dimethoxypyrimidin-2-yl)aminocarbonyl)-3-chloro-1-methyl-4-(5-methyl-5H,6H-1,4,2-dioxadin-3-yl)pyrazole-5-sulfonamide; for rice, wheat, and barley
05/04/2010US7709509 disorders of lipid and/or carbohydrate metabolism, metabolic disorders, central nervous system disorders; 3-{2-Chloro-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-ylmethoxy]-phenyl}-4H-[1,2,4]oxadiazole-5-one
05/04/2010US7709505 2-methyl-4-isobutoxy-6-[N-(5-carboxypyridin-2-yl)carbamoyl]benzofuran; 2-methyl-4-isobutoxy-6-[N-(5-carboxypyridin-2-yl)carbamoyl]benzofuran; type 2 diabetes
05/04/2010US7709503 2-chloro-6-(4-{[(3,4-dichloro-5-methyl-1H-pyrrol-2-yl)carbonyl]amino}piperidin-1-yl)-N-methoxypyrimidine-4-carboxamide; 1-[4-(aminocarbonyl)-6-chloro-2-pyridinyl]4-piperidinyl 4-bromo-5-methyl-1H-pyrrole-2-carboxylate;
05/04/2010US7709500 Chemical compounds
05/04/2010US7709487 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
05/04/2010US7709481 peroxisome proliferator activator receptor (PPARdelta) agonist; type-2 diabetes, atherosclerosis, cardiovascular disorders; 3-{2-Chloro-4-[4-methyl-2-(1-methyl-cyclohexyl)-oxazol-5-ylmethoxy]-phenyl}-4H-[1,2,4]oxadiazol-5-one
05/04/2010US7709480 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer
05/04/2010US7709479 Quinazoline derivatives and their use as pharmaceuticals
05/04/2010US7709477 Triheterocyclic Compounds; small cell lung cancer, follicular lymphoma, non-small cell lung cancer, non-Hodgkin's disease lymphoma, or acute myelocytic leukemia
05/04/2010US7709473 5-[2-(6-tert-Butyl-3-oxo-2,3-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-ylamino)-ethoxy]-nicotinic acid methyl ester; inhibitors of glycogen synthase kinase 3 (GSK-3); diabetes, dementia, Alzheimer's Disease, bipolar disorder, stroke, schizophrenia, depression, hair loss, cancer
05/04/2010US7709466 Pyridazinone derivatives, methods for their production and their use as pharmaceuticals
05/04/2010CA2440419C Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors.
05/04/2010CA2437767C Heterocyclic inhibitors of erk2 and uses thereof
05/04/2010CA2399196C Pyrimidine compounds
04/2010
04/29/2010WO2010048514A1 Synthesis of 2-aminobenzoxazole compounds
04/29/2010WO2010048010A1 2,5-disubstituted piperidine orexin receptor antagonists
04/29/2010WO2010047737A2 Antimicrobial indoline compounds for treatment of bacterial infections
04/29/2010WO2010047369A1 Agent for treatment of diabetic nephropathy
04/29/2010WO2010047120A1 PYRIDINE DERIVATIVE HAVING SUBSTITUTED HETERO RING AND SUBSTITUTED γ-GLUTAMYLAMINO GROUP, AND ANTI-FUNGAL AGENT COMPRISING SAME
04/29/2010WO2010046931A2 Antifungal compounds containing benzothiazinone, benzoxazinone or benzoxazolinone and process thereof
04/29/2010WO2010045948A1 Isoquinolinone derivatives as nk3 antagonists
04/29/2010WO2010020432A3 Compounds for treatment of duchenne muscular dystrophy
04/29/2010US20100105920 Preparation of isoxazolin-3-ylacylbenzenes
04/29/2010US20100105915 Chemokine receptor binding heterocyclic compounds
04/29/2010US20100105899 Integrated Photoactive Small Molecules and Uses Thereof
04/29/2010US20100105894 Cyclopropane compounds and pharmaceutical use thereof
04/29/2010US20100105814 Ultraviolet absorbent and polymer material containing the same
04/29/2010US20100105767 Compounds, compositions and methods
04/29/2010US20100105747 Hydroxymethyl ether hydroisoindoline tachykinin receptor antagonists
04/29/2010US20100105737 PYRIDINE DERIVATIVES SUBSTITUTED WITH HETEROCYCLIC RING AND gamma-GLUTAMYLAMINO GROUP, AND ANTIFUNGAL AGENTS CONTAINING SAME
04/29/2010US20100105712 Chemical compounds
04/29/2010US20100105709 6-Butyl-2-methoxy-5-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-3-phenylpyrimidin-4(3H)-one; for hypertension, cardiac disease, arteriosclerosis, kidney disease, stroke, dyslipidemia, obesity, diabetes, nonalcoholic steatohepatitis, dementia and/or Alzheimer's disease in a mammal
04/29/2010US20100105694 Substituted pyrazinone derivatives for use as a medicine
04/29/2010US20100105684 Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments
04/29/2010US20100105682 Cyclopropyl-piperazine compounds as calcium channel blockers
04/29/2010US20100105681 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors
04/29/2010US20100105680 Substituted dimethylcyclobutyl compounds, their preparation and use in medicaments
04/29/2010US20100105679 5-pyridinone substituted indazoles
04/29/2010US20100105678 Novel anxiolytic compounds
04/29/2010US20100105676 Fused heterocyclic compounds useful as kinase modulators
04/29/2010US20100105674 Chemical Compounds
04/29/2010US20100105673 Substituted aminofuranones and their use
04/29/2010US20100105668 Quinazoline derivatives
04/29/2010US20100105667 Quinoxaline- and Quinoline-Carboxamide Derivatives
1 ... 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 ... 647